Harmony Biosciences To Participate In Two Investor Conferences In November

Rhea-AI Summary

Harmony Biosciences (Nasdaq: HRMY) announced participation in two upcoming virtual investor conferences. CEO John C. Jacobs will engage in fireside chats and host investor meetings at the Jefferies London Healthcare Conference on November 18-19 and the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22 and 30. The fireside chat audio will be available on-demand on Harmony's investor website. Harmony focuses on innovative therapies for rare neurological diseases and aims to address unmet medical needs.

PLYMOUTH MEETING, Pa., Nov. 11, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:

• Jefferies London Healthcare Conference
• Fireside Chat: A pre-recorded fireside chat will be available on-demand beginning on Thursday, November 18 at 8:00am GMT / 3:00am ET through Friday, November 19 at 5:00pm GMT / 12:00pm ET
• 1x1 Meetings: Thursday, November 18, 2021 and Friday, November 19, 2021
• Piper Sandler 33rd Annual Virtual Healthcare Conference
• Fireside Chat: A pre-recorded fireside chat will be available on-demand beginning on Monday, November 22^nd at 10:00am ET
• 1x1 Meetings: Tuesday, November 30, 2021

The audio webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences 
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact: 
Patti Bank
ICR Westwicke
415-513-1284
ir@harmonybiosciences.com 

Harmony Biosciences Media Contact: 
Nancy Leone 
215-891-6046 
nleone@harmonybiosciences.com  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-two-investor-conferences-in-november-301421739.html

SOURCE Harmony Biosciences

FAQ

What is Harmony Biosciences' participation in the Jefferies London Healthcare Conference?

Harmony Biosciences will have a pre-recorded fireside chat available on-demand from November 18 at 8:00 am GMT to November 19 at 5:00 pm GMT.

When will the Piper Sandler 33rd Annual Virtual Healthcare Conference take place?

The Piper Sandler conference will feature a fireside chat on November 22 at 10:00 am ET and 1x1 meetings on November 30, 2021.

How can I access the audio of Harmony Biosciences' fireside chats?

The audio webcasts of the fireside chats will be available on Harmony's investor page at https://ir.harmonybiosciences.com/.

What is Harmony Biosciences focused on?

Harmony Biosciences is focused on developing innovative therapies for patients with rare neurological diseases.

Who is the CEO of Harmony Biosciences?

The CEO of Harmony Biosciences is John C. Jacobs.